Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07065864 · ClinicalTrials.gov registry record · NA
Ketone Esters for Optimization of Operator Performance in Hypoxia
A NA study of Hypoxia, sponsored by Florida Institute for Human and Machine Cognition.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT07065864: Completed NA study of Hypoxia, sponsored by Florida Institute for Human and Machine Cognition.
NCT07065864 is a NA study of Hypoxia that has completed, run by Florida Institute for Human and Machine Cognition. The registered enrollment target is 17 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07065864, a NA study of Hypoxia, has completed, sponsored by Florida Institute for Human and Machine Cognition.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of the study was to investigate effects of an orally administered ketone ester drink on endurance exercise performance during acute extreme hypoxia. Drinking this ketone supplement increases energy substrates known as ketone bodies in the blood, which may also act as metabolic signaling molecules. The ketone drink used in this study is recognized by the FDA as generally regarded as safe (GRAS). Some reports suggest that high ketone levels may enhance one's ability to tolerate hypoxia.
Primary Outcome
Evaluate submaximal exercise performance and physiologic reserve in hypoxia after consuming the ketone ester or placebo drink. Submaximal steady state VO2 relative to VO2max is the primary dependent variable. High altitude environments limit oxygen availability in circulation and working tissues, leading to a decreased physiological reserve during physical exertion. This contributes to a reduction in aerobic power (i.e. maximal rate of oxygen uptake, VO2max) an average of 6.3% per 1000m of elev
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Ketone ester
Study Locations (1)
Florida
- Florida Institute for Human and Machine Cognition - Pensacola
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2023-11-14 |
| Phase | NA |
What the finished NCT07065864 record still lists
NCT07065864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07065864 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07065864 about?
NCT07065864 is a clinical study titled "Ketone Esters for Optimization of Operator Performance in Hypoxia". The primary purpose of the study was to investigate effects of an orally administered ketone ester drink on endurance exercise performance during acute extreme hypoxia. Drinking this ketone supplement increases energy substrates known as ketone bodies in the blood, which may also act as metabolic si...
What is the current status of trial NCT07065864?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-08-04. Estimated completion is 2023-11-14.
What conditions does trial NCT07065864 study?
This clinical trial studies the following conditions: Hypoxia.
What interventions are being tested in trial NCT07065864?
The interventions under investigation include: Placebo (OTHER), Ketone ester (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07065864?
This trial is sponsored by Florida Institute for Human and Machine Cognition, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07065864 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07065864's enrollment target sits among peer trials
17 26th of 39 higher than 14 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Structural Modification In Supraglottic Airway Device
RECRUITING · NA
-
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI